Ditchcarbon
  • Contact
  1. Organizations
  2. Genovac AG
Public Profile
Pharmaceutical Preparation Manufacturing
DE
updated a month ago

Genovac AG Sustainability Profile

Company website

Genovac AG, headquartered in Germany, is a leading player in the biotechnology industry, specialising in the development of innovative antibody discovery and engineering solutions. Founded in 2000, the company has established itself as a trusted partner for pharmaceutical and biotechnology firms, offering a range of services that include monoclonal antibody production and custom assay development. With a strong presence in Europe and North America, Genovac AG is renowned for its unique proprietary technologies that streamline the antibody discovery process, significantly reducing time-to-market for therapeutic candidates. The company has achieved notable milestones, including collaborations with major pharmaceutical companies, which underscore its market position as a key contributor to advancements in biopharmaceutical research. Genovac AG continues to drive innovation, making it a pivotal entity in the evolving landscape of biotechnology.

DitchCarbon Score

How does Genovac AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

59

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Genovac AG's score of 59 is higher than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.

74%

Let us know if this data was useful to you

Genovac AG's reported carbon emissions

Inherited from Danaher Corporation

Genovac AG, headquartered in Germany, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. However, the company is part of a corporate family under Danaher Corporation, which influences its climate commitments and initiatives. As a current subsidiary of Danaher Corporation, Genovac AG's climate strategies and targets are aligned with those set by its parent company. Danaher has established various sustainability initiatives, including commitments to the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP). These initiatives aim to drive significant reductions in greenhouse gas emissions across their operations. While specific reduction targets for Genovac AG are not detailed, the overarching goals from Danaher Corporation suggest a commitment to improving environmental performance and reducing carbon footprints. This includes efforts to enhance energy efficiency and transition to renewable energy sources, although specific metrics or timelines for Genovac AG are not provided. In summary, while Genovac AG does not have publicly available emissions data or specific reduction targets, it is positioned within a framework of sustainability initiatives led by Danaher Corporation, reflecting a commitment to addressing climate change and reducing carbon emissions in the industry.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

201920202021202220232024
Scope 1
138,341,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 2
219,166,000
000,000,000
000,000,000
000,000,000
000,000,000
00,000,000
Scope 3
-
-
-
-
-
-

How Carbon Intensive is Genovac AG's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Genovac AG's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Genovac AG's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Genovac AG is in DE, which has a medium grid carbon intensity relative to other regions.

Genovac AG's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Genovac AG has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Genovac AG's Emissions with Industry Peers

ImmunoPrecise Antibodies Ltd.

CA
•
Pharmaceutical Preparation Manufacturing
Updated 16 days ago

Genscript Biotech

US
•
Research and development services (73)
Updated 16 days ago

Curia

US
•
Pharmaceutical Preparation Manufacturing
Updated 8 days ago

Abveris Inc.

US
•
Chemicals nec
Updated 16 days ago

Zymeworks Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 16 days ago

Ablexis, LLC

US
•
Pharmaceutical Preparation Manufacturing
Updated 6 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251118.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy